IFNA 抗体 (AA 24-189)
Our Local Distributor
北京 101111
Quick Overview for IFNA 抗体 (AA 24-189) (ABIN7620085)
抗原
See all IFNA 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 24-189
-
原理
- Interferon Alpha (IFNa) Polyclonal Antibody
-
序列
- Cys24~Asp189
-
产品特性
- The Interferon Alpha (IFNa) Polyclonal Antibody (Species: Bovine) has been validated for the following applications: WB, IHC, ICC, IP.
-
纯化方法
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
anti-Interferon alpha (IFNA) (AA 28-227) antibody
IFNA 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) antibodyIFNA 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-192) antibodyIFNA 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-189) antibodyIFNA 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 1-187) antibodyIFNA 适用: 豚鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-181) antibodyIFNA 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) antibodyIFNA 适用: 大鼠 FACS 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 24-181) antibodyIFNA 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C3 unconjugated
anti-Interferon alpha (IFNA) (AA 47-191) antibodyIFNA 适用: 小鸡 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon alpha (IFNA) (AA 23-187) antibodyIFNA 适用: 犬 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.5 mg/mL
-
缓冲液
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- IFNA (Interferon alpha (IFNA))
-
别名
- IFNa
-
UniProt
- P07348
-
途径
- JAK/STAT Signaling, TLR signaling, Hepatitis C, Inflammasome
抗原
-
